Hints and tips:
Showing results for Gambro Renal Products, Inc.
...Patients with the condition commonly suffer from a kidney cancer called renal cell carcinoma that often spreads to other parts of the body....
...“We continue to believe that the market continues to under appreciate both Keytruda’s potential as well as multiple other products,” he said....
...But the disappointing IPO cast a pall over what had been positive recent listings from exchanges operator Bats Global Markets and dialysis provider American Renal Associates....
...However, Baxter closed in September on its $4bn acquisition of Swedish renal business Gambro and that should render savings....
...Gambro has since sold several businesses, making the current bid not comparable. Baxter reported third quarter income of $583m on sales of $3.5bn including $629m from renal products....
...Guido Oelkers, Gambro chief executive, said the Swedish group and US-based Baxter shared a strong heritage in renal care and that the move would give them the muscle “to shape our industry for the future...
...Baxter spent $4bn buying Swedish dialysis-product maker Gambro, but it was the world’s second biggest copper producer that really splashed the cash....
...The products enable doctors to avoid amputating the feet of diabetics....
...The German company said it planned to acquire Liberty Dialysis Holdings, a US holding company comprising Liberty Dialysis and Renal Advantage, for $1.7bn including assumed debt, adding about 260 dialysis...
...He died of renal failure in hospital in New York City....
...Just last year, Investor acquired Gambro, the world’s largest maker of kidney dialysis products, for $5.4 billion....
...But, coming against this week’s safety concerns about GlaxoSmithKline’s Avandia diabetes drug, top-level departures at Pfizer, and Roche’s setback with US approval for its new renal anaemia drug, big pharma...
...Gambro, which had revenues of $2bn (€1.65bn) last year, has been part of the Investor sphere since 1996 and supplies renal and blood products and services....
...FMC is acquiring Renal Care Group for $3.5bn, or $48 a share, adding to its own 87,000 patients in the US the more than 30,000 of the Tennessee-based group....
...The acquisition of Renal Care Group is expected to be significantly earnings enhancing and will make Fresenius the largest dialysis services provider in the US....
International Edition